comparemela.com

Latest Breaking News On - Eric weisblum - Page 8 : comparemela.com

Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD

Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Eric weisblumSilo pharma incColumbia universityChief executive officerSilo pharmaLooking statements

Silo Pharma s (SILO) SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis

Silo Pharma s (SILO) SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric weisblumSilo pharma incUniversity of marylandSilo pharmaChief executive officer

Silo Pharma s SPU-21 Peptide Shows Positive Results Against

Human tissue study assessed SPU-21’s efficiency, optimization, and binding affinity ENGLEWOOD CLIFFS, NJ, Oct. 16, 2023 (GLOBE NEWSWIRE) Silo.

Eric weisblumSilo pharma incUniversity of marylandChief executive officerSilo pharmaLooking statementsNasdaq siloSilo pharma

Silo Pharma Initiates Human Factor Study of SPC-15 for the Treatment of PTSD

Study to test effectiveness of Instructional System Designs model for Intranasal SPC-15 ENGLEWOOD CLIFFS, NJ, Oct. 11, 2023 Silo Pharma, Inc. , a developmental stage biopharmaceutical.

Eric weisblumGlobenewswire incColumbia universitySilo pharma incInstructional system designsChief executive officerSilo pharmaLooking statements

Silo Pharma Announces Positive Data on SPC-15 for PTSD and

Pre-IND submission to FDA targeted for first quarter 2024 Silo partners with Kymanox for SPC-15 ENGLEWOOD CLIFFS, NJ, Sept. 20, 2023 .

United statesEric weisblumColumbia universitySilo pharma incDrug administrationInvestigational new drugUnited states foodNorth carolina unitedSilo pharmaLooking statementsNasdaq siloSilo pharmaPre investigational new drug

vimarsana © 2020. All Rights Reserved.